发布网友 发布时间:2022-04-29 14:52
共1个回答
热心网友 时间:2023-10-12 23:39
1. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, Miura Y, Simons JW, and Dong JT (2005) Frequent somatic mutations of the ATBF1 transcription factor in human prostate cancer. Nat Genet. 37: 407-412.
2. Chen C, Guo P, Sun X, Dong XY, Sethi P, Cheng X, Zhou J, Ling J, Simons JW, Lingrel JB, and Dong JT (2005) KLF5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem. 280:41553-41561.
3. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW, and Dong JT (2005) Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene. 24:3319-3327, 2005.
4. Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, and Dong JT (2006) FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting AR signaling in prostate cancer. Cancer Res. 66:6998-7006.
5. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC (1995) KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 268:884-886.
6.Hongxia Wang, Bingbing Liu, Chao Zhang, Guoyuan Peng, Min Liu, Dengwen Li, Feng Gu, Quan Chen, Jin-Tang Dong, Li Fu, and Jun Zhou. Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. Journal of Pathology 218--76-85. 2009-5-1